About US
Contact us
-
Takeda receives shareholders’ approval to acquire ShireTakeda Pharmaceutical has secured shareholder approval for the issuance of its shares necessary to implement the proposed $62bn acquisition of Shire. The Japanese pharmaceutical company received at l2018/12/6
-
Boehringer and Domain Therapeutics form CNS drug discovery allianceBoehringer Ingelheim has signed a drug discovery collaboration and licensing agreement with Domain Therapeutics for the development of new drugs to treat central nervous system (CNS) diseases. The mu2018/12/6
-
UCB to invest £1bn in the UK Life Sciences Sector DealBelgian biopharmaceutical company UCB has agreed to invest approximately £1bn ($1.27bn) as part of a collaboration between the UK government and life sciences industry intended to support health2018/12/5
-
FDA agrees accelerated approval pathway for GBT’s voxelotorThe US Food and Drug Administration (FDA) has granted San Francisco-based Global Blood Therapeutics (GBT)’s sickle cell disease (SCD) therapy voxelotor an accelerated approval under the subpart H path2018/12/5
-
GSK wraps up promised Horlicks sell-off in £3.1B deal with UnileverAfter weighing options and offers for its Horlicks drinks brand in India for several months, GlaxoSmithKline signed off on a £3.1 billion sale to Unilever. The cash will help GSK cover the cos2018/12/4
-
GlaxoSmithKline, looking to pump up in new favorite oncology, buys Tesaro for $5.1BTesaro has been busy looking to sell itself. And now it's found itself a buyer in GlaxoSmithKline, which recently rejigged to refocus on cancer. GSK is shelling out $5.1 billion to acquire the oncolo2018/12/4
-
Women with pregnancy losses are at risk of cardiovascular diseaseResearch from the UK’s University of Cambridge and the University of North Carolina in the US has revealed women have anincreased risk of cardiovascular disease from pregnancy losses and hav2018/12/3
-
Innovent and Hutchison to test sintilimab and fruquintinib combinationInnovent Biologics (Suzhou) has entered into a global collaboration agreement to evaluate the safety of its sintilimab in combination with Hutchison MediPharma’s fruquintinib to treat patients with ad2018/12/3
-
Roche subsidiary Genentech to acquire Jecure TherapeuticsSwiss firm Roche Group’s affiliate Genentech has agreed to acquire US biotechnology company Jecure Therapeutics to strengthen its position in the treatment of liver diseases. Based in San Diego, Cali2018/11/30
-
X4 Pharmaceuticals signs agreement to merge with Arsanis subsidiaryX4 Pharmaceuticals has signed a definitive agreement to merge with a wholly owned subsidiary of Arsanis in an all-stock transaction. The merger is set to result in a combined company operating under2018/11/30